(BLX) Foreign Trade Bank of Latin - Overview
Sector: Financial Services | Industry: Banks - Regional | Exchange: NYSE (USA) | Market Cap: 1.956m USD | Total Return: 44.6% in 12m
Industry Rotation: +1.5
Avg Turnover: 7.77M
EPS Trend: 92.3%
Rev. Trend: 42.2%
Warnings
No concerns identified
Tailwinds
Avwap Ph Week
Banco Latinoamericano de Comercio Exterior, S.A. (BLX), headquartered in Panama, functions as a multinational bank dedicated to financing foreign trade across Latin America and the Caribbean. The institution operates through Commercial and Treasury segments, providing short- and medium-term bilateral loans, syndicated credits, and structured trade finance such as factoring and leasing. Its client base includes financial institutions, corporations, and sovereign entities.
The company utilizes a specialized finance business model that focuses on facilitating cross-border commerce, often serving as a bridge between regional exporters and global markets. Unlike traditional retail banks, trade finance institutions primarily manage risk through self-liquidating assets tied directly to the movement of physical goods. This sector is heavily influenced by regional commodity prices and the overall volume of global trade flows.
Investors can further evaluate the companys historical performance and valuation metrics on ValueRay. Banco Latinoamericano de Comercio Exterior, S.A. remains a key player in the economic integration of its target regions by providing essential liquidity and credit guarantees for international transactions.
- Latin American trade volume fluctuations impact core commercial lending revenue
- Net interest margin sensitivity to Federal Reserve monetary policy shifts
- Credit quality performance across diverse sovereign and corporate loan portfolios
- Regional economic stability and GDP growth in key South American markets
- Efficiency ratios and funding costs influenced by institutional deposit stability
| Net Income: 231.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 15.21 > 1.0 |
| NWC/Revenue: -933.2% < 20% (prev -684.1%; Δ -249.1% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.21b > Net Income 231.6m |
| Net Debt (2.37b) to EBITDA (233.7m): 10.13 < 3 |
| Current Ratio: 0.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.1m) vs 12m ago 16.55% < -2% |
| Gross Margin: 54.06% > 18% (prev 0.34%; Δ 5.37k% > 0.5%) |
| Asset Turnover: 4.57% > 50% (prev 6.53%; Δ -1.96% > 0%) |
| Interest Coverage Ratio: 0.24 > 6 (EBITDA TTM 233.7m / Interest Expense TTM 488.9m) |
| A: -0.41 (Total Current Assets 2.02b - Total Current Liabilities 7.59b) / Total Assets 13.74b |
| B: 0.07 (Retained Earnings 934.6m / Total Assets 13.74b) |
| C: 0.01 (EBIT TTM 119.2m / Avg Total Assets 13.07b) |
| D: 0.12 (Book Value of Equity 1.48b / Total Liabilities 12.03b) |
| Altman-Z'' Score: -2.25 = D |
| DSRI: 1.30 (Receivables 121.5m/127.0m, Revenue 597.7m/809.4m) |
| GMI: 0.63 (GM 54.06% / 33.94%) |
| AQI: 1.03 (AQ_t 0.85 / AQ_t-1 0.83) |
| SGI: 0.74 (Revenue 597.7m / 809.4m) |
| TATA: -0.07 (NI 231.6m - CFO 1.21b) / TA 13.74b) |
| Beneish M-Score: -3.36 (Cap -4..+1) = AA |
Over the past week, the price has changed by +5.66%, over one month by -2.39%, over three months by +13.77% and over the past year by +44.62%.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 65.5 | 18.6% |
P/E Forward = 8.3752
P/S = 6.0544
P/B = 1.1821
P/EG = 1.7665
Revenue TTM = 597.7m USD
EBIT TTM = 119.2m USD
EBITDA TTM = 233.7m USD
Long Term Debt = 4.09b USD (from longTermDebt, last quarter)
Short Term Debt = 247.4m USD (from shortTermDebt, last quarter)
Debt = 4.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.37b USD (from netDebt column, last quarter)
Enterprise Value = 4.04b USD (1.96b + Debt 4.35b - CCE 2.27b)
Interest Coverage Ratio = 0.24 (Ebit TTM 119.2m / Interest Expense TTM 488.9m)
EV/FCF = 3.33x (Enterprise Value 4.04b / FCF TTM 1.21b)
FCF Yield = 30.03% (FCF TTM 1.21b / Enterprise Value 4.04b)
FCF Margin = 202.8% (FCF TTM 1.21b / Revenue TTM 597.7m)
Net Margin = 38.75% (Net Income TTM 231.6m / Revenue TTM 597.7m)
Gross Margin = 54.06% ((Revenue TTM 597.7m - Cost of Revenue TTM 274.5m) / Revenue TTM)
Gross Margin QoQ = 94.34% (prev 93.92%)
Tobins Q-Ratio = 0.29 (Enterprise Value 4.04b / Total Assets 13.74b)
Interest Expense / Debt = 2.66% (Interest Expense 115.7m / Debt 4.35b)
Taxrate = 21.0% (US default 21%)
NOPAT = 94.1m (EBIT 119.2m * (1 - 21.00%))
Current Ratio = 0.27 (Total Current Assets 2.02b / Total Current Liabilities 7.59b)
Debt / Equity = 2.55 (Debt 4.35b / totalStockholderEquity, last quarter 1.71b)
Debt / EBITDA = 10.13 (Net Debt 2.37b / EBITDA 233.7m)
Debt / FCF = 1.95 (Net Debt 2.37b / FCF TTM 1.21b)
Total Stockholder Equity = 1.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.77% (Net Income 231.6m / Total Assets 13.74b)
RoE = 14.36% (Net Income TTM 231.6m / Total Stockholder Equity 1.61b)
RoCE = 2.09% (EBIT 119.2m / Capital Employed (Equity 1.61b + L.T.Debt 4.09b))
RoIC = 1.73% (NOPAT 94.1m / Invested Capital 5.44b)
WACC = 3.98% (E(1.96b)/V(6.31b) * Re(8.15%) + D(4.35b)/V(6.31b) * Rd(2.66%) * (1-Tc(0.21)))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 44.72 | Cagr: 1.23%
[DCF] Terminal Value 80.82% ; FCFF base≈1.21b ; Y1≈795.6m ; Y5≈363.8m
[DCF] Fair Price = 305.5 (EV 11.55b - Net Debt 2.37b = Equity 9.18b / Shares 30.1m; r=6.0% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 92.33 | EPS CAGR: 18.50% | SUE: N/A | # QB: 0
Revenue Correlation: 42.21 | Revenue CAGR: 9.19% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=6.48 | Chg30d=+3.10% | Revisions=+20% | GrowthEPS=+6.1% | GrowthRev=+9.5%
EPS next Year (2027-12-31): EPS=7.05 | Chg30d=+3.52% | Revisions=+20% | GrowthEPS=+8.9% | GrowthRev=+10.0%
[Analyst] Revisions Ratio: +20%